Xiaohou Wu

2.1k total citations
93 papers, 1.7k citations indexed

About

Xiaohou Wu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiaohou Wu has authored 93 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 30 papers in Cancer Research and 23 papers in Oncology. Recurrent topics in Xiaohou Wu's work include Prostate Cancer Treatment and Research (13 papers), Cancer-related Molecular Pathways (12 papers) and Extracellular vesicles in disease (11 papers). Xiaohou Wu is often cited by papers focused on Prostate Cancer Treatment and Research (13 papers), Cancer-related Molecular Pathways (12 papers) and Extracellular vesicles in disease (11 papers). Xiaohou Wu collaborates with scholars based in China, United States and Singapore. Xiaohou Wu's co-authors include Chunli Luo, Yao Zhang, Zhen Quan, Yunfeng He, Lixue Chen, Lin Yang, Dan Wang, Xuedong Song, Gang Chen and Bai‐Cheng He and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Carbohydrate Polymers.

In The Last Decade

Xiaohou Wu

93 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaohou Wu China 25 1.2k 683 288 260 198 93 1.7k
Xudong Yao China 21 1.1k 0.9× 613 0.9× 289 1.0× 214 0.8× 161 0.8× 35 1.9k
Bin Zhu China 27 1.8k 1.5× 937 1.4× 321 1.1× 264 1.0× 229 1.2× 82 2.7k
Stefania Cannito Italy 29 872 0.7× 582 0.9× 203 0.7× 440 1.7× 190 1.0× 63 2.7k
Guo Chen China 22 779 0.6× 412 0.6× 204 0.7× 185 0.7× 92 0.5× 108 1.5k
Jinhai Fan China 27 912 0.7× 381 0.6× 414 1.4× 461 1.8× 170 0.9× 109 2.0k
Cheng Fang China 22 872 0.7× 607 0.9× 219 0.8× 197 0.8× 112 0.6× 57 1.4k
Pengfei Liu China 23 722 0.6× 236 0.3× 167 0.6× 242 0.9× 145 0.7× 79 1.3k
Shumin Dong China 16 1.1k 0.9× 689 1.0× 439 1.5× 275 1.1× 121 0.6× 29 1.8k
Fei Long China 23 1.0k 0.8× 622 0.9× 375 1.3× 260 1.0× 165 0.8× 100 1.7k

Countries citing papers authored by Xiaohou Wu

Since Specialization
Citations

This map shows the geographic impact of Xiaohou Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohou Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohou Wu more than expected).

Fields of papers citing papers by Xiaohou Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohou Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohou Wu. The network helps show where Xiaohou Wu may publish in the future.

Co-authorship network of co-authors of Xiaohou Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohou Wu. A scholar is included among the top collaborators of Xiaohou Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohou Wu. Xiaohou Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wu, Xiaohou, et al.. (2023). A new treatment of concealed penis: symmetrical pterygoid flap surgery. International braz j urol. 49(6). 740–748. 3 indexed citations
3.
Chen, Xiong, Miao Liu, Zhen Quan, et al.. (2022). Lycopene enhances the sensitivity of castration-resistant prostate cancer to enzalutamide through the AKT/EZH2/ androgen receptor signaling pathway. Biochemical and Biophysical Research Communications. 613. 53–60. 14 indexed citations
4.
Yu, Chaowen, Li Luo, Ting Li, et al.. (2021). Identification of the metabolic signatures of prostate cancer by mass spectrometry‐based plasma and urine metabolomics analysis. The Prostate. 81(16). 1320–1328. 13 indexed citations
5.
Du, Zhongbo, Li Luo, Wei Sun, et al.. (2021). Systematic Evaluation for the Influences of the SOX17/Notch Receptor Family Members on Reversing Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cells. Frontiers in Oncology. 11. 607291–607291. 12 indexed citations
6.
Liu, Jiayu, Zhen Quan, Yingying Gao, Xiaohou Wu, & Yongbo Zheng. (2021). MicroRNA-199b-3p suppresses malignant proliferation by targeting Phospholipase Cε and correlated with poor prognosis in prostate cancer. Biochemical and Biophysical Research Communications. 576. 73–79. 13 indexed citations
7.
Fan, Jiaxin, et al.. (2018). HepaCAM Regulates Warburg Effect of Renal Cell Carcinoma via HIF-1α/NF-κB Signaling Pathway. Urology. 127. 61–67. 5 indexed citations
8.
Wang, Yin, Xiaohou Wu, Xue Yang, et al.. (2015). PLCε knockdown inhibits prostate cancer cell proliferation via suppression of Notch signalling and nuclear translocation of the androgen receptor. Cancer Letters. 362(1). 61–69. 27 indexed citations
9.
Wang, Xiaorong, Xue Yang, Wang Yin, et al.. (2015). 5-Azacytidine inhibits the proliferation of bladder cancer cells via reversal of the aberrant hypermethylation of the hepaCAM gene. Oncology Reports. 35(3). 1375–1384. 17 indexed citations
10.
Wang, Dong & Xiaohou Wu. (2015). In vitro and in vivo targeting of bladder carcinoma with metformin in combination with cisplatin. Oncology Letters. 10(2). 975–981. 19 indexed citations
11.
12.
Yang, Xue, Xuedong Song, Shi‐You Chen, et al.. (2015). Exosomal Hsp70 mediates immunosuppressive activity of the myeloid-derived suppressor cells via phosphorylation of Stat3. Medical Oncology. 32(2). 453–453. 86 indexed citations
13.
Yang, Xue, et al.. (2015). Expression of hepaCAM inhibits bladder cancer cell proliferation via a Wnt/β-catenin-dependent pathwayin vitroandin vivo. Cancer Biology & Therapy. 16(10). 1502–1513. 19 indexed citations
14.
Luo, Chunli, et al.. (2014). Hypoxia promotes 786-O cells invasiveness and resistance to sorafenib via HIF-2α/COX-2. Medical Oncology. 32(1). 419–419. 31 indexed citations
15.
Chen, Gang, Yao Zhang, & Xiaohou Wu. (2014). 786-0 Renal cancer cell line-derived exosomes promote 786-0 cell migration and invasion in vitro. Oncology Letters. 7(5). 1576–1580. 25 indexed citations
16.
Yang, Lin, Xiaohou Wu, Dan Wang, Chunli Luo, & Lixue Chen. (2013). Bladder cancer cell-derived exosomes inhibit tumor cell apoptosis and induce cell proliferation in vitro. Molecular Medicine Reports. 8(4). 1272–1278. 137 indexed citations
17.
Jiang, Xiaoliang, Yao Zhang, Chunli Luo, & Xiaohou Wu. (2012). Targeting Renal Cell Carcinoma with Gambogic Acid in Combination with Sunitinib in Vitro and in Vivo. Asian Pacific Journal of Cancer Prevention. 13(12). 6463–6468. 13 indexed citations
18.
He, Yunfeng, Xiaohou Wu, Chunli Luo, Lei Wang, & Jie Lin. (2010). Functional significance of the hepaCAM gene in bladder cancer. BMC Cancer. 10(1). 83–83. 18 indexed citations
19.
Chen, Yong, Xiaohou Wu, Jia Liu, et al.. (2010). Distribution of Convergent Afferents Innervating Bladder and Prostate at Dorsal Root Ganglia in Rats. Urology. 76(3). 764.e1–764.e6. 22 indexed citations
20.
Wu, Xiaohou. (2008). Effect of hepaCAM gene on biological behavior of TCCB cells in vitro. Di-san junyi daxue xuebao. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xudong Yao Breakdown of academic impact, for papers by Bin Zhu Breakdown of academic impact, for papers by Stefania Cannito Breakdown of academic impact, for papers by Guo Chen Breakdown of academic impact, for papers by Jinhai Fan Breakdown of academic impact, for papers by Cheng Fang Breakdown of academic impact, for papers by Pengfei Liu Breakdown of academic impact, for papers by Shumin Dong Breakdown of academic impact, for papers by Fei Long
Rankless by CCL
2026